• Something wrong with this record ?

Molecular mechanism(s) of regulation(s) of c-MET/HGF signaling in head and neck cancer

S. Raj, KK. Kesari, A. Kumar, B. Rathi, A. Sharma, PK. Gupta, SK. Jha, NK. Jha, P. Slama, S. Roychoudhury, D. Kumar

. 2022 ; 21 (1) : 31. [pub] 20220126

Language English Country Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't, Review

Persistent link   https://www.medvik.cz/link/bmc22019464

Head and neck cancer is the sixth most common cancer across the globe. This is generally associated with tobacco and alcohol consumption. Cancer in the pharynx majorly arises through human papillomavirus (HPV) infection, thus classifying head and neck squamous cell carcinoma (HNSCC) into HPV-positive and HPV-negative HNSCCs. Aberrant, mesenchymal-epithelial transition factor (c-MET) signal transduction favors HNSCC progression by stimulating proliferation, motility, invasiveness, morphogenesis, and angiogenesis. c-MET upregulation can be found in the majority of head and neck squamous cell carcinomas. c-MET pathway acts on several downstream effectors including phospholipase C gamma (PLCγ), cellular Src kinase (c-Src), phosphotidylinsitol-3-OH kinase (PI3K), alpha serine/threonine-protein kinase (Akt), mitogen-activated protein kinase (MAPK), and wingless-related integration site (Wnt) pathways. c-MET also establishes a crosstalk pathway with epidermal growth factor receptor (EGFR) and contributes towards chemoresistance in HNSCC. In recent years, the signaling communications of c-MET/HGF in metabolic dysregulation, tumor-microenvironment and immune modulation in HNSCC have emerged. Several clinical trials have been established against c-MET/ hepatocyte growth factor (HGF) signaling network to bring up targeted and effective therapeutic strategies against HNSCC. In this review, we discuss the molecular mechanism(s) and current understanding of c-MET/HGF signaling and its effect on HNSCC.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22019464
003      
CZ-PrNML
005      
20220804135702.0
007      
ta
008      
220720s2022 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12943-022-01503-1 $2 doi
035    __
$a (PubMed)35081970
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Raj, Sibi $u Amity Institute of Molecular and Stem Cell Research (AIMMSCR), Amity University Uttar Pradesh, Noida, 201313, India
245    10
$a Molecular mechanism(s) of regulation(s) of c-MET/HGF signaling in head and neck cancer / $c S. Raj, KK. Kesari, A. Kumar, B. Rathi, A. Sharma, PK. Gupta, SK. Jha, NK. Jha, P. Slama, S. Roychoudhury, D. Kumar
520    9_
$a Head and neck cancer is the sixth most common cancer across the globe. This is generally associated with tobacco and alcohol consumption. Cancer in the pharynx majorly arises through human papillomavirus (HPV) infection, thus classifying head and neck squamous cell carcinoma (HNSCC) into HPV-positive and HPV-negative HNSCCs. Aberrant, mesenchymal-epithelial transition factor (c-MET) signal transduction favors HNSCC progression by stimulating proliferation, motility, invasiveness, morphogenesis, and angiogenesis. c-MET upregulation can be found in the majority of head and neck squamous cell carcinomas. c-MET pathway acts on several downstream effectors including phospholipase C gamma (PLCγ), cellular Src kinase (c-Src), phosphotidylinsitol-3-OH kinase (PI3K), alpha serine/threonine-protein kinase (Akt), mitogen-activated protein kinase (MAPK), and wingless-related integration site (Wnt) pathways. c-MET also establishes a crosstalk pathway with epidermal growth factor receptor (EGFR) and contributes towards chemoresistance in HNSCC. In recent years, the signaling communications of c-MET/HGF in metabolic dysregulation, tumor-microenvironment and immune modulation in HNSCC have emerged. Several clinical trials have been established against c-MET/ hepatocyte growth factor (HGF) signaling network to bring up targeted and effective therapeutic strategies against HNSCC. In this review, we discuss the molecular mechanism(s) and current understanding of c-MET/HGF signaling and its effect on HNSCC.
650    _2
$a zvířata $7 D000818
650    _2
$a protokoly protinádorové kombinované chemoterapie $x škodlivé účinky $x terapeutické užití $7 D000971
650    _2
$a nádorové biomarkery $7 D014408
650    _2
$a management nemoci $7 D019468
650    _2
$a náchylnost k nemoci $7 D004198
650    _2
$a chemorezistence $x genetika $7 D019008
650    _2
$a energetický metabolismus $7 D004734
650    _2
$a nádory hlavy a krku $x etiologie $x metabolismus $x patologie $x terapie $7 D006258
650    _2
$a hepatocytární růstový faktor $x metabolismus $7 D017228
650    _2
$a lidé $7 D006801
650    _2
$a imunita $7 D007109
650    _2
$a protoonkogenní proteiny c-met $x metabolismus $7 D019859
650    12
$a signální transdukce $7 D015398
650    _2
$a výsledek terapie $7 D016896
650    _2
$a nádorové mikroprostředí $x genetika $x imunologie $7 D059016
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Kesari, Kavindra Kumar $u Department of Applied Physics, School of Science, Aalto University, 00076, Espoo, Finland
700    1_
$a Kumar, Arun $u Mahavir Cancer Institute & Research Center, Phulwarisharif, Patna, Bihar, 801505, India
700    1_
$a Rathi, Brijesh $u Laboratory for Translational Chemistry and Drug Discovery, Department of Chemistry, Hansraj College, University of Delhi, Delhi, India
700    1_
$a Sharma, Ashok $u Department of Biochemistry, All India Institute of Medical Science (AIIMS), Ansari Nagar, New Delhi, Bharat, 110029, India
700    1_
$a Gupta, Piyush Kumar $u Department of Life Sciences, School of Basic Sciences and Research, Sharda University, Greater Noida, 201310, India
700    1_
$a Jha, Saurabh Kumar $u Department of Biotechnology, School of Engineering and Technology (SET), Sharda University, Greater Noida, UP, 201310, India
700    1_
$a Jha, Niraj Kumar $u Department of Biotechnology, School of Engineering and Technology (SET), Sharda University, Greater Noida, UP, 201310, India
700    1_
$a Slama, Petr $u Department of Animal Morphology, Physiology and Genetics, Faculty of AgriSciences, Mendel University in Brno, Brno, Czech Republic. petr.slama@mendelu.cz
700    1_
$a Roychoudhury, Shubhadeep $u Department of Life Science and Bioinformatics, Assam University, Silchar, 788011, India. shubhadeep1@gmail.com
700    1_
$a Kumar, Dhruv $u Amity Institute of Molecular and Stem Cell Research (AIMMSCR), Amity University Uttar Pradesh, Noida, 201313, India. dkumar13@amity.edu $1 https://orcid.org/0000000325869397
773    0_
$w MED00008245 $t Molecular cancer $x 1476-4598 $g Roč. 21, č. 1 (2022), s. 31
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35081970 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220720 $b ABA008
991    __
$a 20220804135655 $b ABA008
999    __
$a ok $b bmc $g 1822883 $s 1170707
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 21 $c 1 $d 31 $e 20220126 $i 1476-4598 $m Molecular cancer $n Mol Cancer $x MED00008245
LZP    __
$a Pubmed-20220720

Find record

Citation metrics

Archiving options